BUSINESS
November 17, 1999 | Bloomberg News
Visx Inc., the No. 1 maker of vision-correction lasers in the U.S., accused rival LaserSight Inc. of wrongly using its patented invention for equipment used in optical surgery. Santa Clara, Calif.-based Visx says in a suit filed in U.S. District Court in Wilmington, Del., that it is the owner of a U.S. patent awarded in 1988 protecting an apparatus that scans the corneal surface of the eye and reshapes it with laser energy to correct problems such as nearsightedness.
ENTERTAINMENT
October 3, 2008 | Reed Johnson, Times Staff Writer
It's too bad that Greg Kinnear couldn't have played Robert Kearns more often in real life. That thought went through my mind last week while watching Kinnear's performance in "Flash of Genius," a new drama based on the story of the cantankerous Detroit engineer who successfully sued Ford and Chrysler for a combined $30 million for infringing on his patent designs for the intermittent windshield wiper. Kinnear apparently never met Kearns, who died of cancer at age 77 in 2005.
BUSINESS
July 15, 2006 | Daniel Yi, Times Staff Writer
Consumers stand to save billions of dollars in prescription drug costs in the next few years as an unprecedented wave of expensive brand-name medications come off patent, facing competition from far-cheaper generic versions. Four of the nation's 10 best-selling prescription medicines -- treating common ailments ranging from high cholesterol to asthma -- are due to lose patent protection starting this year through 2010.
BUSINESS
May 11, 2007 | From Bloomberg News
Bristol-Myers Squibb Co. said Thursday that it would plead guilty to criminal charges to end a U.S. antitrust case arising from a bungled patent settlement over the drug maker's blood thinner Plavix. The New York-based company said it would admit to two counts of providing false statements to a government agency. The maximum fine for the charges is $1 million. Bristol-Myers said the false statements were made by "a former Bristol-Myers Squibb senior executive."
ENTERTAINMENT
January 25, 2006 | Steven Barrie-Anthony, Times Staff Writer
Scott Mitchell Rosenberg will not stay at a certain upscale New York hotel, no matter what you say to persuade him otherwise. He remembers vividly the moment when, traveling on business, he realized that his BlackBerry didn't get service in the hotel. That's OK, thought Rosenberg, chairman of Los Angeles-based Platinum Studios -- he unsheathed a second BlackBerry, with a different cellular carrier, which he keeps on his belt for emergencies like this one. It didn't work either.
CALIFORNIA | LOCAL
March 2, 2007 | Tracy Weber and Charles Ornstein, Times Staff Writers
It was to be the final medical procedure for Ruben Navarro, an altruistic end to the life of a critically ill 26-year-old who doctors said had no chance to recover. Staffers at Sierra Vista Regional Medical Center in San Luis Obispo were to disconnect him from the machine pumping oxygen into his lungs. After his heart stopped, transplant surgeons were to remove his organs so they could be used to save the lives of others. But in the late night quiet of an operating room Feb.
BUSINESS
December 4, 1988 | BARRY STAVRO, Times Staff Writer
The phone call that changed Thomas Glaze's life came from his attorney in September, 1986. Monoclonal Antibodies, Glaze's biotechnology company in Mountain View, Calif., had unexpectedly lost a patent case at the U.S. Court of Appeals in Washington. A rival biotech company, Hybritech, sued Monoclonal Antibodies for infringing a Hybritech patent by selling biotechnology-produced diagnostic kits used in pregnancy tests.
BUSINESS
February 7, 2003 | David Streitfeld, Times Staff Writer
For decades, finicky children have been eating peanut butter and jelly sandwiches with the crust removed. From a legal point of view, however, the lunchbox staple was invented on a patio in Fargo, N.D., in 1995. David Geske, who ran a packaged ice business, was entertaining his friend Len Kretchman, a consultant. For lunch, their kids wanted peanut butter and jelly with the bread trimmed and folded over.
BUSINESS
November 20, 2007 | From Bloomberg News
Allergan Inc., the maker of the glaucoma treatment Lumigan, sued seven companies it said were improperly selling related products as ways to grow eyelashes. The companies sell cosmetics with names such as MassiveLash, DermaLash, Luxette, Age Intervention and MD Lash Factor, Allergan said Nov. 7 in a lawsuit filed in U.S. District Court in Santa Ana. All contain compounds called prostaglandins and infringe a patent for using the substance to grow eyelashes, the company said.
BUSINESS
February 24, 2009 | Carol J. Williams
When does a great idea become a patentable invention? That was a question easier to answer when Thomas Edison came up with the lightbulb and Whitcomb Judson devised the zipper -- Industrial Age innovations that clearly fit with old ideas of what it meant to invent something. But a recent case before the U.S. Court of Appeals for the Federal Circuit points up the difficulty of making such judgments in the age of the Internet. Bernard Bilski and Rand Warsaw of WeatherWise USA Inc.